Bausch Health (BHC)
(Delayed Data from NYSE)
$8.71 USD
+0.09 (1.04%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $8.72 +0.01 (0.11%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
Brokerage Reports
0 items in cart
Bausch Health Cos Inc. [BHC]
Reports for Purchase
Showing records 141 - 147 ( 147 total )
Company: Bausch Health Cos Inc.
Industry: Medical - Generic Drugs
Company: Bausch Health Cos Inc.
Industry: Medical - Generic Drugs
Legacy SEC Investigation Resolved; Liver Disease Portfolio Broadened; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Bausch Health Cos Inc.
Industry: Medical - Drugs
Further Progress Made on Multiple Fronts; Raising Price Target to $25
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Bausch Health Cos Inc.
Industry: Medical - Drugs
Company: Bausch Health Cos Inc.
Industry: Medical - Drugs
Multiple Positive Developments; Awaiting Further Organic Growth; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Bausch Health Cos Inc.
Industry: Medical - Drugs
Company: Bausch Health Cos Inc.
Industry: Medical - Drugs
New Name and Perhaps Brighter Future; Generics Could Make Growth Challenging; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R